Fangzhou Inc. was honored as an “Outstanding Growth Story in Hong Kong Stocks” at the China Capital Market Development Forum. The company reported a revenue increase of 12.9% year-on-year, reaching RMB 1.5 billion, with a net profit of RMB 12.5 million. Fangzhou’s registered user base grew to 52.8 million, with 11.9 million monthly active users. They unveiled their new AI system, “XingShi” Large Language Model, at the conference, aiming to enhance chronic disease management. Fangzhou also announced partnerships with Innovent Biologics and Zhejiang Otsuka Pharmaceutical to promote digital health management in support of the “Healthy China 2030” initiative.

Read more at GlobeNewswire: Fangzhou Named ‘Outstanding Growth Story in Hong Kong